Data as of Sep 19, 2026 · Based on 28 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Brands AI recommends here
Named in 96% of answers
Named in 93% of answers
Named in 79% of answers
Named in 75% of answers
The venture capital landscape for cannabis has evolved significantly, shifting focus from plant-touching multi-state operators (MSOs) to ancillary tech, compliance platforms, biotech, and international medical…
The venture capital landscape for cannabis has evolved significantly, shifting focus from plant-touching multi-state operators (MSOs) to ancillary tech, compliance platforms, biotech, and international medical markets.
The most prominent and active venture capital and private equity firms specializing in the cannabis sector include:
If by **“most active”** you mean firms with the largest number of cannabis startup investments—not necessarily the largest check sizes—the current data points to a fairly concentrated group. ### Leading cannabis-focused VCs Firm | Recent investment count* | Typical focus
If by “most active” you mean firms with the largest number of cannabis startup investments—not necessarily the largest check sizes—the current data points to a fairly concentrated group.
| Firm | Recent investment count* | Typical focus |
|---|---|---|
| Casa Verde Capital | 27 | Cannabis tech, software, healthcare; seed through Series B |
| Poseidon Asset Management | 26 | Cannabis, software/SaaS; seed and Series A |
| Phyto Partners | 14 | Ancillary cannabis businesses, software, advertising |
| CanopyBoulder | 100+ historical investments | Early-stage/ancillary cannabis businesses |
| Merida Capital Holdings | Significant historical activity | Cannabis infrastructure, technology and services |
| Entourage Effect Capital | Significant historical activity | Cannabis and ancillary businesses, growth capital |
| Gotham Green Partners | Significant historical activity | Consumer, cannabis and broader CPG |
*The first three figures come from a database updated in August 2026 and ranked by number of relevant cannabis startup investments.
Casa Verde and Poseidon stand out in the current data. Casa Verde says it has evaluated thousands of opportunities since 2015 and invests across financing stages, while Poseidon has been dedicated to cannabis investing since 2013.
The distinction between plant-touching and ancillary businesses matters a lot. Cannabis software, payments, compliance, POS, data, logistics and other infrastructure generally have access to a broader VC universe than companies directly cultivating or selling cannabis.
For an ancillary/technology startup, I'd put particular attention on:
For very early-stage companies, CanopyBoulder is also notable historically; CB Insights lists 114 investments for its accelerator program.
One caveat: “active” can mean number of deals, dollars deployed, or investments made recently, and those produce different lists. The current 2026 database ranking is specifically based on number of cannabis startup investments, so it shouldn't be interpreted as a ranking by capital deployed.
If you're fundraising, I can also give you a 2026 cannabis VC target list of ~25 firms, with check size, stage, plant-touching vs. ancillary, geography, and notable portfolio companies.
The distinction between plant-touching and ancillary businesses matters a lot. Cannabis software, payments, compliance, POS, data, logistics and other infrastructure generally have access to a broader VC universe than companies directly cultivating or selling cannabis.
For an ancillary/technology startup, I'd put particular attention on:
For very early-stage companies, CanopyBoulder is also notable historically; CB Insights lists 114 investments for its accelerator program.
If by **“most active”** you mean firms with the largest number of cannabis startup investments and continued activity, the current leaders are: Firm | Approx. cannabis deals* | Typical stage | Best known for --- | --- | --- | ---
If by “most active” you mean firms with the largest number of cannabis startup investments and continued activity, the current leaders are:
| Firm | Approx. cannabis deals* | Typical stage | Best known for |
|---|---|---|---|
| Casa Verde Capital | 27 | Seed–Series B | Cannabis-adjacent technology, consumer, health/wellness |
| Poseidon Asset Management | 26 | Seed–Series A | Cannabis tech, software, SaaS, ancillary businesses |
| Phyto Partners | 14 | Seed–Series C | Cannabis technology, software, advertising, consumer |
| OrganiGram | 8 | Later/strategic | Cannabis, biotech, medical |
| Arcview Collective | — | Seed/early | Broad cannabis ecosystem; angel/VC hybrid |
*Current investment counts from an August 2026 investor database; counts vary depending on how follow-ons, strategic investments and portfolio companies are classified.
Beyond those four, I'd put Entourage Effect Capital, Merida Capital, Gotham Green Partners, 7thirty Capital, F4 Fund, KEY Investment Partners, and Green Lion Partners on a broader cannabis-investor list. These become especially interesting depending on whether you're plant-touching, ancillary, biotech, software, consumer, or infrastructure.
One important caveat: cannabis VC has been relatively quiet compared with 2019–2021. Private equity and traditional VC pulled back substantially as cannabis operators struggled with taxes, regulation, banking and profitability. In 2024, debt represented about 92% of cannabis capital raised, according to Viridian data cited by the Wall Street Journal. The Wall Street Journal The picture may be changing, though: 2026 federal rescheduling developments have already prompted cannabis-pharma companies to report renewed VC interest.
If you're raising capital for a cannabis startup, I can also give you a ranked list of the top 20 cannabis VCs, including fund size, recent investments, check size, stage, geography, partner names, and whether they invest in plant-touching companies.
The cannabis venture capital and private equity landscape has evolved past the speculative boom of the late 2010s. The most active and enduring firms in the space today focus on systematic due diligence, regulatory navigation, ancillary tech, and scalable plant-touching or consumer brands. The most active and…
The cannabis venture capital and private equity landscape has evolved past the speculative boom of the late 2010s. The most active and enduring firms in the space today focus on systematic due diligence, regulatory navigation, ancillary tech, and scalable plant-touching or consumer brands.
The most active and prominent cannabis-focused venture capital and investment firms include:
If by **“most active”** you mean firms with a meaningful number of cannabis startup investments—not simply the biggest cannabis funds—the current landscape is fairly concentrated. Based on an August 2026 investor database ranking, the leaders are **Casa Verde Capital, Poseidon Asset Management, and Phyto Partners**.…
If by “most active” you mean firms with a meaningful number of cannabis startup investments—not simply the biggest cannabis funds—the current landscape is fairly concentrated.
Based on an August 2026 investor database ranking, the leaders are Casa Verde Capital, Poseidon Asset Management, and Phyto Partners.
| Firm | Approx. cannabis investments* | Typical stage | What they’re known for |
|---|---|---|---|
| Casa Verde Capital | ~27 | Seed–Series B | Cannabis technology, consumer, health/wellness, infrastructure |
| Poseidon Asset Management | ~26 | Seed–Series A | Cannabis software, data, retail tech, ancillary businesses |
| Phyto Partners | ~14 | Seed–Series C | Cannabis tech, consumer, advertising/media |
| OrganiGram | ~8 | Later/strategic | Cannabis, biotech, medical |
| Tuatara Capital | — | Growth | Cannabis infrastructure and established operators |
| Entourage Effect Capital | — | Growth/late-stage | Broad cannabis ecosystem, including ancillary businesses |
| Merida Capital Holdings | — | Growth | Cannabis infrastructure, technology and operators |
| Gotham Green Partners | — | Series A–growth | Cannabis consumer and branded products |
*Investment counts vary substantially by database methodology. The first three have the clearest current activity ranking: Casa Verde 27, Poseidon 26 and Phyto 14 in the latest global cannabis VC dataset.
1. Casa Verde — probably the most important name to know. It has been cannabis-focused since 2015, evaluates companies across the financing lifecycle, and explicitly targets scalable, capital-efficient businesses. Its recent activity includes a 2025 Series A in UK medical-cannabis clinic Mamedica.
2. Poseidon — particularly compelling for cannabis software, data, compliance, retail infrastructure and other ancillary technology. Its disclosed portfolio includes Headset, Flowhub, Wurk, Happy Cabbage Analytics and Green Flower, among others.
3. Phyto Partners — one of the more consistently active dedicated cannabis VCs, with investments spanning seed through later rounds and a particular emphasis on technology and cannabis-adjacent businesses.
4. Entourage Effect Capital / Merida / Gotham Green — I'd put these on the list if you're raising a larger Series A/B or growth round, rather than a tiny pre-seed.
5. Arcview — different model, but valuable if you need cannabis-industry introductions and a broad investor network. Its Collective Fund invests at seed/early stage, generally making $75K–$250K investments over the life of a company.
One important distinction: the best cannabis investor depends heavily on what you're building. A cannabis SaaS/compliance company should target a somewhat different set of investors than a plant-touching cultivator, cannabis CPG brand, biotech company, or dispensary operator. The market is also starting to change as U.S. cannabis policy becomes more favorable to institutional investment; Reuters reported in April 2026 that rescheduling was already generating renewed VC interest in cannabis-derived pharmaceuticals.
If you tell me what your cannabis company does, stage (pre-seed/seed/A/B), and how much you're raising, I can give you a ranked list of 15–25 investors that are the best fit, including recent investments, check sizes, partner names, and how to approach each one.
Wurk
The cannabis venture capital and private equity landscape has evolved past the speculative rush of early legalization. Today, active firms primarily focus on ancillary technology, compliance platforms, biotechnology, and scalable B2B operations rather than direct plant-touching cultivation in saturated…
The cannabis venture capital and private equity landscape has evolved past the speculative rush of early legalization. Today, active firms primarily focus on ancillary technology, compliance platforms, biotechnology, and scalable B2B operations rather than direct plant-touching cultivation in saturated markets.
The most prominent and active venture capital and investment firms in the cannabis sector include:
If by **“most active”** you mean firms that have repeatedly deployed capital into cannabis companies—not just generalist VCs that have made one cannabis bet—the current leaders are fairly concentrated. ### Most active cannabis-focused VCs Firm | Approx. cannabis investments* | Typical focus | Best fit
If by “most active” you mean firms that have repeatedly deployed capital into cannabis companies—not just generalist VCs that have made one cannabis bet—the current leaders are fairly concentrated.
| Firm | Approx. cannabis investments* | Typical focus | Best fit |
|---|---|---|---|
| Casa Verde Capital | 27 | Cannabis, software, healthcare, consumer | Seed → Series B |
| Poseidon Asset Management | 26 | Cannabis, SaaS, software, infrastructure | Seed → Series A |
| Phyto Partners | 14 | Cannabis, software, advertising/brands | Seed → Series C |
| Entourage Effect Capital | 60+ portfolio companies | Broad cannabis ecosystem, infrastructure, brands | Growth + selective early stage |
| Arcview / Arcview Ventures | Numerous member-funded companies | Early-stage cannabis, biotech, tech, consumer | Seed / early stage |
| Merida Capital | Large cannabis-focused portfolio | Infrastructure, operators, ancillary businesses | Series A → growth |
| Gotham Green Partners | Large cannabis portfolio | Consumer, brands, operators, infrastructure | Growth / later stage |
*Investment counts vary substantially by database methodology, so I would not treat the numbers as directly comparable. The latest available investor database puts Casa Verde, Poseidon and Phyto at the top by number of tracked cannabis startup investments.
1. Casa Verde Capital — probably the first firm I'd approach for a cannabis startup. It has been cannabis-focused since 2015, invests across financing stages, and has a particularly strong emphasis on scalable, capital-efficient businesses. Its portfolio includes cannabis software, payments, compliance, healthcare, cultivation technology and consumer companies.
2. Poseidon Asset Management — one of the most consistently active dedicated cannabis investors, particularly attractive for cannabis technology, SaaS, software and ancillary businesses. Current tracking shows 26 U.S. cannabis startup investments.
3. Entourage Effect Capital (EEC) — one of the industry's longest-running institutional investors. EEC says it has deployed $140M+ across 60+ portfolio companies and is currently deploying Fund III; importantly, it has an early-stage allocation through its Arcview Ventures Seed Fund.
4. Phyto Partners — particularly worth looking at if you're building technology, software, marketing/data infrastructure or other ancillary cannabis businesses. It currently ranks third among tracked cannabis VCs by investment count.
5. Merida Capital — a strong candidate once a company has moved beyond a very early seed round, especially for cannabis infrastructure and businesses with meaningful operating scale.
6. Gotham Green Partners — another important institutional cannabis investor, generally more relevant once there's substantial revenue, traction or a larger financing requirement.
7. Arcview Ventures — somewhat different from a conventional VC. Its Collective Fund invests in seed/early-stage cannabis companies, typically making $75K–$250K investments over the life of an investment, while leveraging its broader investor network.
I'd narrow the list based on what you're building:
One important caveat: cannabis VC activity has contracted considerably compared with the 2019–22 boom, with debt/private credit taking a much larger role in cannabis financing. The Wall Street Journal So “active” in 2026 is better measured by recent deployment and willingness to write new checks, rather than simply historical portfolio size.
If you tell me what your cannabis company does, how much you're raising, and whether you're pre-revenue or revenue-generating, I can give you a ranked list of 15–20 VCs that are the best targets right now, including check size, stage, recent investments, partner names, and pitch/contact links.
1. Casa Verde Capital — probably the first firm I'd approach for a cannabis startup. It has been cannabis-focused since 2015, invests across financing stages, and has a particularly strong emphasis on scalable, capital-efficient businesses. Its portfolio includes cannabis software, payments, compliance, healthcare, cultivation technology and consumer companies.
2. Poseidon Asset Management — one of the most consistently active dedicated cannabis investors, particularly attractive for cannabis technology, SaaS, software and ancillary businesses. Current tracking shows 26 U.S. cannabis startup investments.
3. Entourage Effect Capital (EEC) — one of the industry's longest-running institutional investors. EEC says it has deployed $140M+ across 60+ portfolio companies and is currently deploying Fund III; importantly, it has an early-stage allocation through its Arcview Ventures Seed Fund.
4. Phyto Partners — particularly worth looking at if you're building technology, software, marketing/data infrastructure or other ancillary cannabis businesses. It currently ranks third among tracked cannabis VCs by investment count.
5. Merida Capital — a strong candidate once a company has moved beyond a very early seed round, especially for cannabis infrastructure and businesses with meaningful operating scale.
6. Gotham Green Partners — another important institutional cannabis investor, generally more relevant once there's substantial revenue, traction or a larger financing requirement.
7. Arcview Ventures — somewhat different from a conventional VC. Its Collective Fund invests in seed/early-stage cannabis companies, typically making $75K–$250K investments over the life of an investment, while leveraging its broader investor network.
I'd narrow the list based on what you're building:
The cannabis venture capital and private equity landscape includes several specialized firms that have consistently deployed capital across plant-touching and ancillary sectors (such as tech, logistics, biotech, and consumer goods): - Casa Verde Capital — Widely recognized as one of the prominent venture capital firms…
The cannabis venture capital and private equity landscape includes several specialized firms that have consistently deployed capital across plant-touching and ancillary sectors (such as tech, logistics, biotech, and consumer goods):
If by **“most active”** you mean dedicated cannabis investors with a meaningful number of deals and continued activity, the current leaders are fairly clear. ### Leading cannabis VC firms 1. **Casa Verde Capital** — probably the strongest overall name. Current databases rank it #1 with roughly **27 tracked cannabis…
If by “most active” you mean dedicated cannabis investors with a meaningful number of deals and continued activity, the current leaders are fairly clear.
I'd narrow the list considerably:
| Your company | VCs I'd prioritize |
|---|---|
| Cannabis software / SaaS | Casa Verde, Poseidon, Phyto, Tuatara |
| Dispensary / retail tech | Casa Verde, Poseidon, Tuatara |
| Compliance / regulatory tech | Casa Verde, Poseidon, Phyto |
| Cannabis CPG / brands | Casa Verde, Phyto, Gotham Green |
| Plant-touching operator | Poseidon, Merida, Entourage Effect, Gotham Green |
| Biotech / medical cannabis | Casa Verde, Phyto, Entourage Effect |
| Series A–C / growth | Entourage Effect, Merida, Gotham Green |
| Pre-seed / seed | Poseidon, Casa Verde, Phyto |
The interesting thing in 2026 is that cannabis VC has shifted heavily toward ancillary/infrastructure businesses—software, payments, compliance, data, insurance, retail infrastructure and biotech—rather than simply funding cultivation and dispensaries. Current investor databases put Casa Verde, Poseidon and Phyto clearly at the top by deal count.
If you're asking because you're raising capital for a cannabis startup, tell me the business model, stage, amount you're raising, and location, and I can give you a much more useful top 10 target investor list ranked by likelihood of investing, including partners to approach and relevant portfolio companies.
The cannabis venture capital landscape is shaped by specialized sector-focused funds and private equity groups that navigate regulatory complexities across plant-touching and ancillary markets. The most prominent and active venture capital and investment firms in the cannabis sector include: - **Casa Verde Capital** –…
The cannabis venture capital landscape is shaped by specialized sector-focused funds and private equity groups that navigate regulatory complexities across plant-touching and ancillary markets.
The most prominent and active venture capital and investment firms in the cannabis sector include: